Effect of genetic African ancestry on EGFR and kidney disease

Journal of the American Society of Nephrology

Volumn 26, Issue 7, 2015, Pages 1682-1692

  Udler, Miriam S ^a,b,c   Nadkarni, Girish N ^a,c,d   Belbin, Gillian ^b,c   Lotay, Vaneet ^c   Wyatt, Christina ^a,d   Gottesman, Omri ^b,c   Bottinger, Erwin P ^a,c,d   Kenny, Eimear E ^b,c,e,f   Peter, Inga ^b,c,e  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Departments of Genetics and Genomic Sciences   (United States)

^c Departments of Charles Bronfman Institute for Personalized Medicine   (United States)

^d Division of Nephrology   (United States)

^e Center for Statistical Genetics   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ELECTROLYTE; APOL1 PROTEIN, HUMAN; APOLIPOPROTEIN; HIGH DENSITY LIPOPROTEIN;

ADULT; AFRICAN; AFRICAN AMERICAN; AGED; ANCESTRY GROUP; APOL1 GENE; ARTICLE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; END STAGE RENAL DISEASE; EUROPEAN AMERICAN; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GLOMERULUS FILTRATION RATE; HAPLOTYPE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; AGE DISTRIBUTION; BLACK PERSON; CAUCASIAN; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; COMPARATIVE STUDY; EPIDEMIOLOGY; ETHNOLOGY; FACTUAL DATABASE; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; INCIDENCE; PHENOTYPE; SEX RATIO; UNITED STATES;

AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; AGED; APOLIPOPROTEINS; COHORT STUDIES; DATABASES, FACTUAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GLOMERULAR FILTRATION RATE; HISPANIC AMERICANS; HUMANS; INCIDENCE; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; RENAL INSUFFICIENCY, CHRONIC; SEX DISTRIBUTION; UNITED STATES;

EID: 84934783968     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014050474     Document Type: Article

References (43)

1. United States Renal Data System: 2013 Annual Data Report, 2013. Available at: http://www.usrds.org/adr.aspx. Accessed May 14, 2014
2. Gallagher D, Visser M, De Meersman RE, Sepulveda D, Baumgartner RN, Pierson RN, Harris T, Heymsfield SB: Appendicular skeletal muscle mass: Effects of age, gender, and ethnicity. J Appl Physiol (1985) 83: 229-239, 1997
3. Stevens LA, Claybon MA, Schmid CH, Chen J, Horio M, Imai E, Nelson RG, Van Deventer M, Wang HY, Zuo L, Zhang YL, Levey AS: Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int 79: 555-562, 2011
4. Patzer RE, McClellan WM: Influence of race, ethnicity and socioeconomic status on kidney disease. Nat Rev Nephrol 8: 533-541, 2012
5. Genovese G, Friedman DJ, RossMD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR: Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329: 841-845, 2010
6. Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, Fryc J, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Vlahov D, Pollak M, Winkler CA: APOL1 genetic variants in focal segmental glomerulosclerosis andHIV-associated nephropathy. J Am Soc Nephrol 22: 2129-2137, 2011
7. Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, Bekele E, Bradman N,WasserWG, Behar DM, Skorecki K: Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 128: 345-350, 2010
8. Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT Jr., Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ; AASK Study InvestigatorsCRIC Study Investigators: APOL1 risk variants, race, and progression of chronic kidney disease.NEngl J Med 369: 2183-2196, 2013
9. Tzur S, Rosset S, Skorecki K, Wasser WG: APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic endstage kidney disease. Nephrol Dial Transplant 27: 1498-1505, 2012
10. Kanji Z, Powe CE, Wenger JB, Huang C, Ankers E, Sullivan DA, Collerone G, Powe NR, Tonelli M, Bhan I, Bernhardy AJ, Dibartolo S, Friedman D, Genovese G, Pollak MR, Thadhani R: Genetic variation in APOL1 associates with younger age at hemodialysis initiation. J Am Soc Nephrol 22: 2091-2097, 2011
11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130: 461-470, 1999
12. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, FeldmanHI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
13. Caulfield T, Fullerton SM, Ali-Khan SE, Arbour L, Burchard EG, Cooper RS, Hardy BJ, Harry S, Hyde-Lay R, Kahn J, Kittles R, Koenig BA, Lee SS, Malinowski M, Ravitsky V, Sankar P, Scherer SW, Seguin B, Shickle D, Suarez-Kurtz G, Daar AS: Race and ancestry in biomedical research: Exploring the challenges. Genome Med 1: 8, 2009
14. Bryc K, Auton A, Nelson MR, Oksenberg JR, Hauser SL, Williams S, Froment A, Bodo JM,Wambebe C, Tishkoff SA, Bustamante CD:Genomewide patterns of population structure and admixture in West Africans and African Americans. Proc Natl Acad Sci U S A 107: 786-791, 2010
15. Price AL, Tandon A, Patterson N, Barnes KC, Rafaels N, Ruczinski I, Beaty TH, Mathias R, Reich D, Myers S: Sensitive detection of chromosomal segments of distinct ancestry in admixed populations. PLoS Genet 5: e1000519, 2009
16. Tang H, Coram M, Wang P, Zhu X, Risch N: Reconstructing genetic ancestry blocks in admixed individuals. Am J Hum Genet 79: 1-12, 2006
17. Bryc K, Velez C, Karafet T, Moreno-Estrada A, Reynolds A, Auton A, Hammer M, Bustamante CD, Ostrer H: Colloquiumpaper: Genome-wide patterns of population structure and admixture among Hispanic/Latino populations. Proc Natl Acad Sci U S A 107[Suppl 2]: 8954-8961, 2010
18. Gravel S, Zakharia F, Moreno-Estrada A, Byrnes JK, Muzzio M, Rodriguez-Flores JL, Kenny EE, Gignoux CR, Maples BK, Guiblet W, Dutil J, Via M, Sandoval K, Bedoya G, Oleksyk TK, Ruiz-Linares A, Burchard EG, Martinez-Cruzado JC, Bustamante CD; 1000 Genomes Project: Reconstructing Native American migrations from wholegenome and whole-exome data. PLoS Genet 9: e1004023, 2013
19. Alexander DH, Novembre J, Lange K: Fast model-based estimation of ancestry in unrelated individuals. Genome Res 19: 1655-1664, 2009
20. Zhou H, Alexander D, Lange K: A quasi-Newton acceleration for highdimensional optimization algorithms. Stat Comput 21: 261-273, 2011
21. Abecasis GR, Auton A, Brooks LD, DePristoMA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA; 1000 Genomes Project Consortium: An integrated map of genetic variation from 1,092 human genomes. Nature 491: 56-65, 2012
22. Radmanesh F, Devan WJ, Anderson CD, Rosand J, Falcone GJ: Accuracy of imputation to infer unobserved APOE epsilon alleles in genome-wide genotyping data [published online ahead of print January 22, 2014]. Eur J Hum Genet 10.1038/ejhg.2013.308
23. Nelson SC, Doheny KF, Pugh EW, Romm JM, Ling H, Laurie CA, Browning SR,Weir BS, Laurie CC: Imputation-based genomic coverage assessments of current human genotyping arrays. G3 (Bethesda) 3: 1795-1807, 2013
24. Howie B, Marchini J, StephensM:Genotype imputationwith thousands of genomes. G3 (Bethesda) 1: 457-470, 2011
25. Peralta CA, Li Y, Wassel C, Choudhry S, Palmas W, SeldinMF, RischN, Siscovick D, Arnett D, Psaty B, Shlipak MG: Differences in albuminuria between Hispanics and whites: An evaluation by genetic ancestry and country of origin: The multi-ethnic study of atherosclerosis. Circ Cardiovasc Genet 3: 240-247, 2010
26. Peralta CA, RischN, Lin F, ShlipakMG, Reiner A, Ziv E, Tang H, Siscovick D, Bibbins-Domingo K: The Association of African Ancestry and elevated creatinine in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Nephrol 31: 202-208, 2010
27. Delanaye P, Mariat C, Maillard N, Krzesinski JM, Cavalier E: Are the creatinine-based equations accurate to estimate glomerular filtration rate in African American populations? Clin J Am Soc Nephrol 6: 906-912, 2011
28. Moreno-Estrada A, Gravel S, Zakharia F, McCauley JL, Byrnes JK, Gignoux CR, Ortiz-Tello PA, Martínez RJ, Hedges DJ, Morris RW, Eng C, Sandoval K, Acevedo-Acevedo S, Norman PJ, Layrisse Z, Parham P, Martínez-Cruzado JC, Burchard EG, Cuccaro ML, Martin ER, Bustamante CD: Reconstructingthe population genetic history of theCaribbean. PLoS Genet 9: e1003925, 2013
29. Goldwasser P, Aboul-MagdA,MaruM: Race and creatinine excretion in chronic renal insufficiency. AmJ Kidney Dis 30: 16-22, 1997
30. Gottesman O, Scott SA, Ellis SB, Overby CL, Ludtke A, Hulot JS, Hall J, Chatani K, Myers K, Kannry JL, Bottinger EP: The CLIPMERGE PGx Program: Clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics. Clin Pharmacol Ther 94: 214-217, 2013
31. Pulley JM, Denny JC, Peterson JF, Bernard GR, Vnencak-Jones CL, Ramirez AH, Delaney JT, Bowton E, Brothers K, Johnson K, Crawford DC, Schildcrout J,Masys DR, Dilks HH,Wilke RA, Clayton EW, Shultz E, Laposata M, McPherson J, Jirjis JN, Roden DM: Operational implementation of prospective genotyping for personalized medicine: The design of the Vanderbilt PREDICT project. Clin Pharmacol Ther 92: 87-95, 2012
32. National Kidney Foundation: Clinical Practice Guidelines for Nutrition in Chronic Renal Failure, 2000. Available at: http://www.kidney. org/professionals/kdoqi/guidelines/doqi-nut.html. Accessed May 14, 2014
33. Friedman DJ, Kozlitina J, Genovese G, Jog P, Pollak MR: Populationbased risk assessment of APOL1 on renal disease. J Am Soc Nephrol 22: 2098-2105, 2011
34. Foster MC, Coresh J, Fornage M, Astor BC, Grams M, Franceschini N, Boerwinkle E, Parekh RS, Kao WH: APOL1 variants associate with increased risk of CKD among African Americans. J Am Soc Nephrol 24: 1484-1491, 2013
35. Freedman BI, Hicks PJ, Bostrom MA, Comeau ME, Divers J, Bleyer AJ, Kopp JB, Winkler CA, Nelson GW, Langefeld CD, Bowden DW: Nonmuscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Nephrol Dial Transplant 24: 3366-3371, 2009
36. Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, Coresh J, Patterson N, Tandon A, Powe NR, Fink NE, Sadler JH, Weir MR, Abboud HE, Adler SG, Divers J, Iyengar SK, Freedman BI, Kimmel PL, Knowler WC, Kohn OF, Kramp K, Leehey DJ, Nicholas SB, Pahl MV, Schelling JR, Sedor JR, Thornley-Brown D, Winkler CA, Smith MW, Parekh RS; Family Investigation ofNephropathy andDiabetes Research Group:MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 40: 1185-1192, 2008
37. Stehman-Breen CO, Gillen D, Steffes M, Jacobs DR Jr., Lewis CE, Kiefe CI, Siscovick D: Racial differences in early-onset renal disease among young adults: The coronary artery risk development in young adults (CARDIA) study. J Am Soc Nephrol 14: 2352-2357, 2003
38. Tayo BO, Teil M, Tong L, Qin H, Khitrov G, Zhang W, Song Q, Gottesman O, Zhu X, Pereira AC, Cooper RS, Bottinger EP: Genetic background of patients from a university medical center in Manhattan: Implications for personalized medicine. PLoS ONE 6: e19166, 2011
39. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC: PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575, 2007
40. Kho AN, Hayes MG, Rasmussen-Torvik L, Pacheco JA, Thompson WK, Armstrong LL, Denny JC, Peissig PL, Miller AW, Wei WQ, Bielinski SJ, Chute CG, Leibson CL, Jarvik GP, Crosslin DR, Carlson CS,Newton KM, Wolf WA, Chisholm RL, Lowe WL: Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genomewide association study. J Am Med Inform Assoc 19: 212-218, 2012
41. Patterson N, Price AL, Reich D: Population structure and eigenanalysis. PLoS Genet 2: e190, 2006
42. Delaneau O, Zagury JF, Marchini J: Improved whole-chromosome phasing for disease and population genetic studies. Nat Methods 10: 5-6, 2013
43. Howie BN, Donnelly P, Marchini J: A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 5: e1000529, 2009